AlzBiomarker
Alzheimer's Disease vs Control: GFAP (CSF)
Meta-analysis Results: Levels of the astrocytic protein GFAP in the CSF did not differ between people with Alzheimer’s disease and controls (effect size = 1.119, p = 0.7355). However, a paucity of data limited the meta-analysis, with only two eligible comparisons.

